We are developing a novel class of synaptic health therapies using cutting-edge precision neuroscience tools. Our targeted drug candidates are designed to safely, rapidly, and durably enhance synaptic function, representing a paradigm shift in the treatment of patients suffering from CNS disorders.
Gate is advancing a clinical-stage pipeline of precision therapies for neuropsychiatric and cognitive disorders that harness new, differentiated mechanisms of action.
Our team of neuroscience leaders, clinicians, and scientists is dedicated to revolutionizing care for patients in desperate need of new treatment options.